Musaffa Logo
Alivus Life Sciences Ltd 543322.BO

Last Updated: Jul 20, 12:00 AM·BSE

543322.BO Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Alivus Life Sciences Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Alivus Life Sciences Ltd

Alivus Life Sciences Ltd. Stock Analysis 543322.BO

India Health Care Small Cap Report:
Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra and currently employs 2,203 full-time employees. The company went IPO on 2021-08-06. The firm is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). The company also develops APIs in the therapeutic areas such as antifungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. The company has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh.
Read More

Alivus Life Sciences Ltd (543322.BO) Chart

Key Statistics of Alivus Life Sciences Ltd (543322.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1,123.80₹1,144.70

Today's Open

₹1,126.35

Volume

45.57K

P/E Ratio (TTM)

24.63

Financial Metrics & Statements of Alivus Life Sciences Ltd (543322.BO)

Super Investors Invested in Alivus Life Sciences Ltd (543322.BO)

FAQ's for Alivus Life Sciences Ltd (543322.BO)

  • As of July 2026, Alivus Life Sciences Ltd 543322.BO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Alivus Life Sciences Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Alivus Life Sciences Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Alivus Life Sciences Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Alivus Life Sciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Alivus Life Sciences Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.